Home |
Free Dividend Report |
Stock Splits Calendar |
BLUE Stock Split History |
Preferred Stock Newsletter |
BLUE Options Chain |
Stock Message Boards |
bluebird bio (BLUE) has 1 split in our BLUE split history database. The split for BLUE took place on November 05, 2021. This was a 1544 for 1000 split, meaning for each 1000 shares of BLUE owned pre-split, the shareholder now owned 1544 shares. For example, a 1000 share position pre-split, became a 1544 share position following the split.
When a company such as bluebird bio splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the BLUE split history from start to finish, an original position size of 1000 shares would have turned into 1544 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into bluebird bio shares, starting with a $10,000 purchase of BLUE, presented on a split-history-adjusted basis factoring in the complete BLUE split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 04/25/2024 | |
Start price/share: | $12.69 | |
End price/share: | $0.91 | |
Dividends collected/share: | $0.00 | |
Total return: | -92.83% | |
Average Annual Total Return: | -23.17% | |
Starting investment: | $10,000.00 | |
Ending investment: | $717.17 | |
Years: | 10.00 |
About bluebird bio |
bluebird bio is a biotechnology company focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector gene addition platform. Co. has two gene therapies: ZYNTEGLO® (betibeglogene autotemcel, also known as beti-cel) and SKYSONA® (elivaldogene autotemcel, also known as eli-cel). ZYNTEGLO is for the treatment of adult and pediatric patients with B-thalassemia who require regular red blood cell transfusions. SKYSONA is for slowing the progression of neurologic dysfunction in boys four to 17 years of age with early active cerebral adrenoleukodystrophy. According to our BLUE split history records, bluebird bio has had 1 split. |
BLUE Split History Table | |
Date | Ratio |
11/05/2021 | 1544 for 1000 |
Healthcare Stock Splits |
BLUE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
BMRA Split History Also explore: BLUE shares outstanding history
Free BLUE Email Alerts:
|
BLUE Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.